NCT03654066
Botox or Botox With Esophageal Dilation in Patients With Achalasia
Enrolling by Invitation
PHASE4Ages 18+InterventionalTreatmentVanderbilt University Medical CenterInvestigator-initiated
~50 participants
Updated 2026-08-03 on ClinicalTrials.gov
What's tested:Botulinum toxin type AEndoscope balloon dilatorPatient reported outcomesBarium esophagram
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
dysphagia score
Measured over 12 months
Conditions
Where it's being run
1 sites across 1 statesTennessee1
Study leadership
- Dhyanesh Patel, MD · PRINCIPAL_INVESTIGATOR · Vanderbilt University Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adults with known diagnosis of achalasia who are NOT candidates for definitive therapy with pneumatic dilation, surgical myotomy, or POEM
Patient undergoing routine care upper endoscopy for achalasia
Exclusion
Less than 18 years old
Previous surgery for reflux or peptic ulcer disease
Significant medical conditions possibly placing subjects at risk to undergo endoscopy
What this trial measures
- dysphagia score12 months
Dysphagia score as measured by patient reported outcomes will be used to compare the two groups. The scale runs from 0 (no symptoms) to 100 (severe symptoms).